Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

drug side effects

This page shows the latest drug side effects news and features for those working in and with pharma, biotech and healthcare.

US says medicine ads should include list prices

US says medicine ads should include list prices

US says medicine ads should include list prices. Hopes the proposal will encourage lower prescription drug prices. ... Right now, drug companies are required to disclose the major side effects a drug can have – but not the effect that buying the drug

Latest news

  • GSK two-drug trial in untreated HIV raises Gilead rivalry GSK two-drug trial in untreated HIV raises Gilead rivalry

    GSK two-drug trial in untreated HIV raises Gilead rivalry. Intends to file the combination later this year to challenge Gilead’s Biktarvy. ... for HIV – with few side effects and drug interactions.

  • GSK sells eczema and psoriasis drug to Dermavant for £250m GSK sells eczema and psoriasis drug to Dermavant for £250m

    that could provide an alternative to topical and oral steroids, which have side effects. ... In phase II trials the drug had a dose-dependent impact on plaque psoriasis lesions, and it is ready to move to phase III testing.

  • ViiV’s two-drug HIV combo backed by CHMP ViiV’s two-drug HIV combo backed by CHMP

    ViiV’ s two-drug HIV combo backed by CHMP. The committee also backs two biosimilar medicines. ... At the moment most patients are treated with three-drug regimens, and ViiV says the two-drug regimens can reduce drug exposure and side effects, as well

  • It’s only money It’s only money

    drug by emphasising potential side effects. ... It is suspected that falsified data was used in the clinical trial of Novartis’s best selling drug Diovan.

  • BMS' Yervoy picks up another indication in Europe BMS' Yervoy picks up another indication in Europe

    found to be more effective than Yervoy with patients reporting a better PFS with fewer side effects. ... The European approval follows a decision by the US Food and Drug Administration’s (FDA) to approve the drug for the same indication back in July

More from news
Approximately 1 fully matching, plus 108 partially matching documents found.

Latest Intelligence

  • Redirecting your patient strategy Redirecting your patient strategy

    But when people are dealing with their condition for so long, it is important that you understand how they're actually managing it, how they're using the drug.”. ... These new companies have developed novel business models based on sharing the data and

  • Choices, choices: the rapidly evolving HIV treatment landscape Choices, choices: the rapidly evolving HIV treatment landscape

    IIs are more potent, with fewer side effects and drug interactions and the top reason for prescribing them is their good tolerability profile. ... As patients differ so do their barriers to adherence, whether this be complexity of the dosing regimen,

  • Patients First Patients First

    to their thoughts on the impact of drug side effects, these are all areas that pharma is already actively engaged with at some level.

  • Patients First Patients First

    to their thoughts on the impact of drug side effects, these are all areas that pharma is already actively engaged with at some level.

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    The G-BA assesses drugs on four criteria: mortality; morbidity (for example, symptom improvement); quality of life; and adverse events (toxicity and side effects). ... A natural question to ask is how the benefit finding impacts the final price of a drug

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Quick links

Infographics

Multimedia